ThinkGenetic is a digital health company specializing in finding individuals at risk of rare conditions. The company detects patients for evaluation, treatment, and clinical trials using validated algorithms, AI technology, and the team's deep experience in genetic and rare diseases. ThinkGenetic collaborates with biopharma, research institutions, healthcare systems, and patient advocacy organizations. ThinkGenetic is a MIT Solve / Horizon Prize winner, Opportunity Machine / Accelerate South, and PULSE@MassChallenge accelerator alumni. For more information, visit https://thinkgenetic.com.